Kennedy Capital Management, Inc. Ligand Pharmaceuticals Inc Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $91,506 - $134,074	-1,846 Reduced 5.17%	33,853 $2.42 Million
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $71,514 - $88,294	1,215 Added 3.52%	35,699 $2.14 Million
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $1.38 Million - $1.57 Million	19,815 Added 135.08%	34,484 $2.49 Million
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $224,722 - $263,767	3,422 Added 30.43%	14,669 $1.08 Million
Q4 2022 Feb 14, 2023	SELL	$61.72 - $96.74 $802 - $1,257	-13 Reduced 0.12%	11,247 $751,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $0 - $107	1 Added 0.01%	11,260 $970,000
Q2 2022 Aug 10, 2022	BUY	$74.52 - $117.06 $40,911 - $64,265	549 Added 5.13%	11,259 $1.01 Million
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $9,973 - $15,913	-105 Reduced 0.97%	10,710 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $48,139 - $62,525	-377 Reduced 3.37%	10,815 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $68,561 - $96,969	-670 Reduced 5.65%	11,192 $1.56 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $348,697 - $480,149	-3,085 Reduced 20.64%	11,862 $1.56 Million
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $9.47 Million - $20.5 Million	-95,145 Reduced 86.42%	14,947 $2.28 Million
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $4.29 Million - $5.65 Million	53,295 Added 93.83%	110,092 $10.9 Million
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $8.85 Million - $12.5 Million	-98,761 Reduced 63.49%	56,797 $5.41 Million
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $496,600 - $899,306	-7,273 Reduced 4.47%	155,558 $17.4 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $5.88 Million - $10 Million	92,717 Added 132.24%	162,831 $11.8 Million
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $1.24 Million - $1.46 Million	12,837 Added 22.41%	70,114 $7.31 Million
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $3.54 Million - $4.93 Million	41,045 Added 252.86%	57,277 $5.7 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $3.23 Million - $3.89 Million	-30,046 Reduced 64.93%	16,232 $1.85 Million
Q1 2019 May 13, 2019	BUY	$105.93 - $142.47 $3.69 Million - $4.97 Million	34,856 Added 305.17%	46,278 $5.82 Million
Q4 2018 Feb 12, 2019	SELL	$128.36 - $272.13 $4.63 Million - $9.81 Million	-36,056 Reduced 75.94%	11,422 $1.55 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $193,440 - $251,432	916 Added 1.97%	47,478 $13 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $154,086 - $212,555	1,022 Added 2.24%	46,562 $9.65 Million
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $111,597 - $147,009	-805 Reduced 1.74%	45,540 $7.52 Million
Q4 2017 Feb 13, 2018	SELL	$128.36 - $147.04 $27,340 - $31,319	-213 Reduced 0.46%	46,345 $6.35 Million
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $5.63 Million - $6.42 Million	46,558	46,558 $6.34 Million

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account